| Sr. number | Part useda | Type of extract | Active strainsb | Method | Reference standard | Effective concentration | Reference |
| 1 | SD | Essential oil | S.a., Enterococcus sp., P.a., E.c., and Salmonella sp. | Filter paper disc diffusion method |
0.5 Mac Farland’s Standard (1.5 108 CFU/mL) | 10 L/disk | [142] |
| 2 | FT | Essential oil | E.c., B.m.,and 27 phytopathogenic bacterial species | Agar diffusion method | Rifampicin | 1.6 mg/mL | [143] |
| 3 | AP | Aqueous, ethanol and ethyl-acetate extracts | A.r.t., Er.c., P.f.,and P.g. | Filter paper disc diffusion method | Chloramphenicol, streptomycin, and tetracycline | 15 mg per disc. | [91] |
| 4 | SD | Essential oil | E.a., S.t., S.a., St.e., E.c., P.a.,and C.a. | Filter paper disc diffusion method | Amoxicillin and cefazolin | 15 L/disk | [144] |
| 5 | FL, FT | Essential oil | A.a., F.o., and R.s. | Filter paper disc diffusion method | NS | 10 and 40 ppm | [95] |
| 6 | FL, LF, TW | Essential oil | Bacilli sp., P.a., Acinetobacter sp., and A.f. | Agar diffusion method | Fleroxacin | 30, 25, 20, 15 and 10 L per well | [145] |
| 7 | SD, ST, LF, RT | Essential oil | S.a., B.s., E.c., P.a., C.a., C.t., M.s., M.c., and M.x. | Agar dilution method | NS | NM | [146] |
| 8 | SD | Essential oil | E.c., B.s., A.n., F.s.,and Rh.s. | Filter paper disc diffusion method | Amoxycillin and flumequine | 300 g/disc | [96] |
| 9 | FT | Essential oil and ethanolic and methanolic extracts | B.c., B.m., B.p., B.s., E.c., K.p., M.l., P.p., P.s., and C.a. | Filter paper disc diffusion method | Cefoperazone, sulbactam, ofloxacin, and netilmicin | 30 mg/mL | [92] |
| 10 | SD | Aqueous/organic extracts | E.f., S.a., E.c., K.p., P.a., Sa.t., S.t., and S.f. | Agar well and disc diffusion method | Chloramphenicol, gentamicin, and ampicillin | NM | [3] |
| 11 | SD | Essential oil | E.c., P.a., S.a., B.s., A.n., and C.a. | Filter paper disc diffusion technique | Ampicillin and miconazole nitrate | 10 L/disk | [113] |
| 12 | SD | Ethanol, methanol, and aqueous extracts | E.c., K.p., P.v., E.a., Sa.t., B.c.,and S.a. | Agar well and disc diffusion method | Streptomycin | NM | [4] |
| 13 | SD | Essential oil | E.c., P.a., S.a., C.a.,and A.n. | Cylinder-plate diffusion method | NS | 0.25 to 2.0% | [147] |
| 14 | FT | Essential oils | S.a., B.c., P.a., E.c.,and C.a. | Disc paper and broth microdilution methods | NS | NM | [148] |
| 15 | SD | Methanol, ethanol, diethyl ether, and hexane extract | E.c., Sa.t., B.c., S.a., C.a.,and As.f. | Filter paper disc diffusion technique | NS | 7.5, 10, 12.5, 15, 20 g/disk | [23] |
| 16 | LF, FL | Crude, chloroform, and methanol extract | E.c. and S.a. | Filter paper disc diffusion method | NS | NM | [93] |
| 17 | FT | Essential oil | HSV-1 and PI-3 | Using Madin-Darby bovine kidney and Vero cell lines | Acyclovir | 0.025 to 0.8 g/mL | [5] |
| 18 | LF | Essential oil | S.a., E.c., K.p., P.a., S.e., C.a. and P.m., A.n.,and F.o. | Filter paper disc diffusion method | Gentamicin, amoxicillin, and nystatin | 5 L/disk | [94] |
| 19 | ST, LF | Hexane extract | M.t. | 96-well sterile microtiter plate assay | NS | 200 g/mL | [63] |
| 20 | SD | Essential oil | S.a., E.c., K.p.,and P.a. | Agar well diffusion method | Imipenem | 50 L/well | [149] |
| 21 | SD | Essential oil | S.a., E.c., S.c.,and St.f. | Filter paper disc diffusion method | Amoxicillin | 10, 50, 100 L/mL | [150] |
| 22 | SD | Essential oil | S.a., B.s., B.m., B.c., S.l., S.h., Sa.t., S.d., S.s., Sh.s., S.b., E.c.,and P.a. | Filter paper disc diffusion method | Streptomycin | 1 g/mL | [151] |
| 23 | FT | Essential oil | C.a. | Agar well and filter paper disc diffusion method | Fluconazole and nystatin | 25 L/well and 15 L/disc | [152] |
| 24 | SD | Methanolic extract | E.c., P.a., S.a., and B.p. | Agar diffusion method | Chloramphenicol and ampicillin | NM | [7] |
| 25 | SD | Aqueous and alcoholic extracts | A.a., M.r.,and A.f. | Agar well diffusion method | NS | NM | [98] |
|
|
AP: aerial part, FL: flower, FT: fruit, LF: leaf, RT: root, SD: seed, ST: stem, and TW: twig. .: Alternaria alternate, A.f.: Alcaligenes faecalis, As.f.: Aspergillus flavus, A.n.: Aspergillus niger, A.r.t.: Agrobacterium radiobacter pv. tumefaciens, B.c.: Bacillus cereus, B.m.: Bacillus megaterium, B.p.: Bacillus pumilus, B.s.: Bacillus subtilis, C.a.: Candida albicans, C.t.: Candida tropicalis, E.a.: Enterobacter aerogenes, Er.c.: Erwinia carotovora, E.c.: Escherichia coli, E.f.: Enterococcus faecalis, F.o.: Fusarium oxysporum, F.s.: Fusarium solani, K.p.: Klebsiella pneumonia, M.c.: Mycobacterium chelonae, M.l.: Micrococcus luteus, M.r.: Mucor rouxii, M.s.: Mycobacterium smegmatis, M.t.: Mycobacterium tuberculosis H37Rv ATCC 27294, M.x.: Mycobacterium xenopi, P.a.: Pseudomona aeruginosa, P.f.: Pseudomonas fluorescens, P.g.: Pseudomonas glycinea, P.m.: Phytopathogenic molds, P.p.: Pseudomonas putida, P.s.: Pseudomonas syringae, P.v.: Proteus vulgaris, R.s.: Rhizoctonia solani, Rh.s.: Rhizopus solani, S.a.: Staphylococcus aureus, S.b.: Shigella boydii, S.c.: Staphylococcus coagulase, S.d.: Shigella dysenteriae, S.e.: Salmonella enteritidis, S.e.: Staphylococcus epidermidis, S.f.: Shigella flexneri, St.f.: Streptococcus faecalis, S.h.: Streptococcus haemolyticus, S.l.: Sarcina lutea, S.s.: Shigella shiga, S.t.: Salmonella typhimurium, Sa.t.: Salmonella typhi, and Sh.s.: Shigella sonnei. HSV-1: herpes simplex virus 1 as a representative of DNA viruses and PI-3: parainfluenza-3 virus (PI-3) as representative of RNA viruses. NS: no reference standard employed and NM: not mentioned.
|